White House launches Disaster.Data.Gov

Laura Pedulli | | Health Exec | Economics

 

The White House’s Office of Science and Technology Policy has launched Disasters.Data.Gov, a public resource to foster collaboration and the continual improvement of disaster-related open data.

The tool offers “new ways to empower first responders, survivors and government officials with the information needed in the wake of a disaster,” according to a White House blog. Some features of the challenge include:

  • “Types of disasters” landing pages, includes pages for earthquakes, floods, hurricanes, severe winter weather, tornadoes and wildfires.
  • Apps and tools to help first responders, emergency managers, volunteer organizations, survivors and other stakeholders.
  • A call to data stewards to encourage stakeholders to open disaster-related datasets from all levels of the government and the private sector.
  • An invitation to join the “Innovation for Disasters” movement.

In concert with the launch, the White House unveiled the first in a series of Innovator Challenges that highlight pressing needs from the disaster preparedness community.

Read the announcement.

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.